Captor Therapeutics SA Price Chart
Captor Therapeutics SA 60Q.F Financial and Trading Overview
| Captor Therapeutics SA stock price | 16.6 EUR |
| Previous Close | 34.3 EUR |
| Open | 34.3 EUR |
| Bid | 33 EUR x N/A |
| Ask | 36.3 EUR x N/A |
| Day's Range | 34.3 - 34.3 EUR |
| 52 Week Range | 21.1 - 38.1 EUR |
| Volume | 5 EUR |
| Avg. Volume | 0 EUR |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
60Q.F Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Captor Therapeutics SA Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 38.1 EUR |
| 52 Week Low | 21.1 EUR |
| 50-Day Moving Average | 33.35 EUR |
| 200-Day Moving Average | 32.4 EUR |
60Q.F Share Statistics
| Avg. Volume (3 month) | 0 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | N/A |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | N/A |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | N/A |
| Operating Margin (ttm) | N/A |
| Gross Margin | N/A |
| EBITDA Margin | N/A |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Q&A For Captor Therapeutics SA Stock
What is a current 60Q.F stock price?
Captor Therapeutics SA 60Q.F stock price today per share is 16.6 EUR.
How to purchase Captor Therapeutics SA stock?
You can buy 60Q.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Captor Therapeutics SA?
The stock symbol or ticker of Captor Therapeutics SA is 60Q.F.
How many shares does Captor Therapeutics SA have in circulation?
The max supply of Captor Therapeutics SA shares is 0.
What is Captor Therapeutics SA Price to Earnings Ratio (PE Ratio)?
Captor Therapeutics SA PE Ratio is now.
What was Captor Therapeutics SA earnings per share over the trailing 12 months (TTM)?
Captor Therapeutics SA EPS is 0 EUR over the trailing 12 months.